Two million 231‐GFP cells overexpressing PCSK9 or an empty vector were injected into the mammary fat pads of NOD/SCID mice and within the 6 weeks period, we examined the development of orthotopic and metastatic tumors (Figure 4G, Figure S4E, Supporting Information). Here, PCSK9 is linked to metastatic neoplasm.